These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395 [TBL] [Abstract][Full Text] [Related]
26. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte demand and substrate supply as factors in the susceptibility to alcoholic liver injury: pathogenesis and prevention. Israel Y; Orrego H Clin Gastroenterol; 1981 May; 10(2):355-73. PubMed ID: 7018748 [TBL] [Abstract][Full Text] [Related]
28. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598 [TBL] [Abstract][Full Text] [Related]
29. New concepts in the pathogenesis of alcoholic liver disease. Albano E Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):749-59. PubMed ID: 19090736 [TBL] [Abstract][Full Text] [Related]
30. Role of alcohol in liver carcinogenesis. McKillop IH; Schrum LW Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921 [TBL] [Abstract][Full Text] [Related]
35. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344 [TBL] [Abstract][Full Text] [Related]
36. Energy balance, physical activity, and cancer risk. Fair AM; Montgomery K Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of disease progression in nonalcoholic fatty liver disease. Jou J; Choi SS; Diehl AM Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293 [TBL] [Abstract][Full Text] [Related]
38. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Li Z; Soloski MJ; Diehl AM Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608 [TBL] [Abstract][Full Text] [Related]